• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

花生过敏负担调查:与青少年健康相关生活质量相关的因素

Peanut allergy burden survey: Factors associated with health-related quality of life in adolescents.

作者信息

McCann William A, Nowak-Wegrzyn Anna, Hass Steven L, Huang Danmeng, Donelson Sarah M

机构信息

Allergy Partners P.A., Asheville, North Carolina, USA.

NYU Grossman School of Medicine, Hassenfeld Children's Hospital, New York, New York, USA.

出版信息

Clin Transl Allergy. 2023 Mar;13(3):e12234. doi: 10.1002/clt2.12234.

DOI:10.1002/clt2.12234
PMID:36973958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10041074/
Abstract

BACKGROUND

Patients with peanut allergy (PA) experience significant burden of illness, which impacts health-related quality of life (HRQoL), particularly in adolescence. There is a paucity of research evaluating drivers of HRQoL scores.

METHODS

A prospective, online survey of adolescents with self-reported, provider-diagnosed PA completed from November 2018 to January 2019 was used to explore drivers of the real-world impact of PA on HRQoL using the Pediatric Quality of Life Inventory 4.0 (PedsQL) and other measures. Univariate and multivariate analyses were used to identify potential factors associated with PedsQL scores and to understand the level of association.

RESULTS

A total of 102 adolescents were included. The final model included 10 variables: race, reported strict peanut avoidance, satisfaction with prophylaxis, moderate-to-severe reaction within the past 12 months, touching peanut as cause of most severe reaction, fear of reaction, age, gender, comorbidities, and daily life limitations. In total, three items were shown to be strong predictors of the PedsQL total score including cause of severe reaction was touching peanut (yes), level of agreement with avoiding peanut (completely agree), and satisfaction with prophylaxis (not very much/not at all).

CONCLUSIONS

There is substantial heterogeneity in the impact of the burden of PA on PedsQL scores across patients. This indicates the importance of shared and individualized decision making for PA management to optimize outcomes and improve HRQoL.

摘要

背景

花生过敏(PA)患者承受着巨大的疾病负担,这会影响与健康相关的生活质量(HRQoL),尤其是在青少年时期。评估HRQoL评分驱动因素的研究较少。

方法

2018年11月至2019年1月对自我报告、经医生诊断为PA的青少年进行了一项前瞻性在线调查,以使用儿童生活质量量表4.0(PedsQL)和其他指标探讨PA对HRQoL的现实世界影响的驱动因素。采用单因素和多因素分析来确定与PedsQL评分相关的潜在因素,并了解关联程度。

结果

共纳入102名青少年。最终模型包括10个变量:种族、报告的严格避免食用花生情况、对预防措施的满意度、过去12个月内的中度至重度反应、接触花生作为最严重反应的原因、对反应的恐惧、年龄、性别、合并症和日常生活限制。总的来说,有三项被证明是PedsQL总分的强预测因素,包括严重反应的原因是接触花生(是)、对避免食用花生的认同程度(完全认同)以及对预防措施的满意度(不太满意/完全不满意)。

结论

PA负担对不同患者PedsQL评分的影响存在很大异质性。这表明在PA管理中进行共同决策和个性化决策对于优化结果和改善HRQoL的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76e/10041074/62fd14af06ac/CLT2-13-e12234-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76e/10041074/e57de4f43022/CLT2-13-e12234-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76e/10041074/62fd14af06ac/CLT2-13-e12234-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76e/10041074/e57de4f43022/CLT2-13-e12234-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76e/10041074/62fd14af06ac/CLT2-13-e12234-g001.jpg

相似文献

1
Peanut allergy burden survey: Factors associated with health-related quality of life in adolescents.花生过敏负担调查:与青少年健康相关生活质量相关的因素
Clin Transl Allergy. 2023 Mar;13(3):e12234. doi: 10.1002/clt2.12234.
2
The Peanut Allergy Burden Study: Impact on the quality of life of patients and caregivers.花生过敏负担研究:对患者及照料者生活质量的影响
World Allergy Organ J. 2021 Feb 15;14(2):100512. doi: 10.1016/j.waojou.2021.100512. eCollection 2021 Feb.
3
Peanut allergy impact on productivity and quality of life (PAPRIQUA): Caregiver-reported psychosocial impact of peanut allergy on children.花生过敏对生产力和生活质量的影响(PAPRIQUA):照顾者报告的儿童花生过敏的心理社会影响。
Clin Exp Allergy. 2020 Nov;50(11):1249-1257. doi: 10.1111/cea.13727. Epub 2020 Sep 12.
4
The Peanut Allergy Burden Study: Real-world impact of peanut allergy on resource utilization and productivity.花生过敏负担研究:花生过敏对资源利用及生产力的实际影响
World Allergy Organ J. 2021 Mar 26;14(3):100525. doi: 10.1016/j.waojou.2021.100525. eCollection 2021 Mar.
5
Psychosocial and productivity impact of caring for a child with peanut allergy.照顾花生过敏儿童对心理社会和生产力的影响。
Allergy Asthma Clin Immunol. 2020 Sep 25;16:83. doi: 10.1186/s13223-020-00477-3. eCollection 2020.
6
APPEAL-1: A multiple-country European survey assessing the psychosocial impact of peanut allergy.APPEAL-1:一项评估花生过敏的心理社会影响的多国欧洲调查。
Allergy. 2020 Nov;75(11):2899-2908. doi: 10.1111/all.14363. Epub 2020 Jul 9.
7
Association of Reaction Symptoms and Eliciting Dose With Health-Related Quality of Life in Children With Peanut Allergy.花生过敏儿童的反应症状及激发剂量与健康相关生活质量的关联
J Allergy Clin Immunol Pract. 2023 Oct;11(10):3195-3202.e4. doi: 10.1016/j.jaip.2023.06.063. Epub 2023 Jul 7.
8
APPEAL-2: A pan-European qualitative study to explore the burden of peanut-allergic children, teenagers and their caregivers.APPEAL-2:一项泛欧的定性研究,旨在探讨花生过敏儿童、青少年及其照顾者的负担。
Clin Exp Allergy. 2020 Nov;50(11):1238-1248. doi: 10.1111/cea.13719. Epub 2020 Sep 15.
9
Oral immunotherapy for peanut allergy: The pro argument.花生过敏的口服免疫疗法:支持观点。
World Allergy Organ J. 2020 Sep 18;13(8):100455. doi: 10.1016/j.waojou.2020.100455. eCollection 2020 Aug.
10
Allergy to Peanuts imPacting Emotions And Life (APPEAL): The impact of peanut allergy on children, teenagers, adults and caregivers in the UK and Ireland.花生过敏对情绪和生活的影响(APPEAL):花生过敏对英国和爱尔兰儿童、青少年、成年人及照料者的影响。
PLoS One. 2022 Feb 7;17(2):e0262851. doi: 10.1371/journal.pone.0262851. eCollection 2022.

引用本文的文献

1
Generic Health-Related Quality of Life of Children With Severe Peanut or Tree Nut Allergy.患有严重花生或坚果过敏症儿童的一般健康相关生活质量
Acta Paediatr. 2025 Jul;114(7):1660-1667. doi: 10.1111/apa.70016. Epub 2025 Feb 6.
2
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy.度普利尤单抗作为花生过敏儿科患者口服免疫疗法的辅助治疗药物。
Allergy. 2025 Mar;80(3):827-842. doi: 10.1111/all.16420. Epub 2024 Dec 14.

本文引用的文献

1
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.口服免疫治疗在 1-3 岁花生过敏儿童中的疗效和安全性(免疫耐受网络 IMPACT 试验):一项随机安慰剂对照研究。
Lancet. 2022 Jan 22;399(10322):359-371. doi: 10.1016/S0140-6736(21)02390-4.
2
Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials.花生(Arachis hypogaea)过敏原粉-dnfp 在儿童和青少年花生过敏中的安全性:3 期和扩展试验的汇总分析。
J Allergy Clin Immunol. 2022 Jun;149(6):2043-2052.e9. doi: 10.1016/j.jaci.2021.12.780. Epub 2021 Dec 29.
3
The Peanut Allergy Burden Study: Real-world impact of peanut allergy on resource utilization and productivity.
花生过敏负担研究:花生过敏对资源利用及生产力的实际影响
World Allergy Organ J. 2021 Mar 26;14(3):100525. doi: 10.1016/j.waojou.2021.100525. eCollection 2021 Mar.
4
The Peanut Allergy Burden Study: Impact on the quality of life of patients and caregivers.花生过敏负担研究:对患者及照料者生活质量的影响
World Allergy Organ J. 2021 Feb 15;14(2):100512. doi: 10.1016/j.waojou.2021.100512. eCollection 2021 Feb.
5
The global burden of illness of peanut allergy: A comprehensive literature review.花生过敏的全球疾病负担:一项全面的文献综述。
Allergy. 2021 May;76(5):1367-1384. doi: 10.1111/all.14666. Epub 2021 Jan 16.
6
Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies.PEPITES 和 PEOPLE 研究中经皮免疫治疗(EPIT)治疗花生过敏后儿童生活质量的改善。
J Allergy Clin Immunol Pract. 2021 Jan;9(1):216-224.e1. doi: 10.1016/j.jaip.2020.08.015. Epub 2020 Aug 22.
7
APPEAL-2: A pan-European qualitative study to explore the burden of peanut-allergic children, teenagers and their caregivers.APPEAL-2:一项泛欧的定性研究,旨在探讨花生过敏儿童、青少年及其照顾者的负担。
Clin Exp Allergy. 2020 Nov;50(11):1238-1248. doi: 10.1111/cea.13719. Epub 2020 Sep 15.
8
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.儿童变应原皮内免疫治疗的疗效和安全性的长期、开放性扩展研究:PEOPLE 研究 3 年结果。
J Allergy Clin Immunol. 2020 Oct;146(4):863-874. doi: 10.1016/j.jaci.2020.06.028. Epub 2020 Jul 10.
9
Peanut Allergy: New Advances and Ongoing Controversies.花生过敏:新进展和持续争议。
Pediatrics. 2020 May;145(5). doi: 10.1542/peds.2019-2102. Epub 2020 Apr 17.
10
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.表皮免疫治疗与安慰剂对花生过敏儿童进食花生蛋白反应的影响:PEPITES 随机临床试验。
JAMA. 2019 Mar 12;321(10):946-955. doi: 10.1001/jama.2019.1113.